Tag Archives: SNN

Sunniva Inc (SNN) Receives a Buy from Canaccord Genuity

In a new note to investors on May 1, an analyst has provided a rating update for the Conglomerates sector company, Sunniva Inc (SNN – Research Report). Analyst Matt Bottomley from Canaccord Genuity rated Sunniva Inc (SNN – Research Report)

Sunniva Inc (SNN) Receives a Rating Update from a Top Analyst

In a latest note to investors, a research analyst has provided a rating update for the Conglomerates sector company, Sunniva Inc (SNN – Research Report). Analyst Matt Bottomley from Canaccord Genuity reiterated a Buy rating, with a C$10 price target

Smith & Nephew Snats (SNN) Receives a Buy from Canaccord Genuity

In a report released yesterday, Kyle Rose from Canaccord Genuity maintained a Buy rating on Smith & Nephew Snats (NYSE: SNN), with a price target of $42. The company’s shares opened today at $35.66. Rose wrote: “We maintain our BUY

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Smith & Nephew Snats (NYSE: SNN) and Pacira Pharmaceuticals (NASDAQ: PCRX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Smith & Nephew Snats (NYSE: SNN) and Pacira Pharmaceuticals (NASDAQ: PCRX). Smith & Nephew Snats (NYSE: SNN) In a report released yesterday, Kyle Rose from

Canaccord Genuity Reiterates a Buy Rating on Smith & Nephew Snats

In a report released yesterday, Kyle Rose from Canaccord Genuity reiterated a Buy rating on Smith & Nephew Snats (NYSE: SNN), with a price target of $45. The company’s shares opened today at $35.22. According to TipRanks.com, Rose is a

Analysts Conflicted on These Healthcare Names: Smith & Nephew Snats (NYSE: SNN), Depomed (NASDAQ: DEPO) and Aldeyra Therapeutics (NASDAQ: ALDX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Smith & Nephew Snats (NYSE: SNN), Depomed (NASDAQ: DEPO) and Aldeyra Therapeutics (NASDAQ: ALDX). Smith & Nephew Snats (NYSE: SNN) Canaccord Genuity analyst Kyle Rose